Provided by Tiger Fintech (Singapore) Pte. Ltd.

Acurx Pharmaceuticals, LLC*

0.3690
-0.0038-1.02%
Post-market: 0.3500-0.0190-5.15%19:05 EDT
Volume:121.65K
Turnover:45.50K
Market Cap:8.13M
PE:-0.42
High:0.3810
Open:0.3750
Low:0.3609
Close:0.3728
Loading ...
Apr 04, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Mar 28, 2025

Major Issues Report

Form 8-K - Current report
Mar 18, 2025

Major Issues Report

Form 8-K - Current report
Mar 17, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 17, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 10, 2025

Major Issues Report

Form 8-K - Current report
Feb 27, 2025

Major Issues Report

Form 8-K - Current report
Feb 04, 2025

Correspondence

Form CORRESP - Correspondence
Jan 31, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jan 07, 2025

Major Issues Report

Form 8-K - Current report
Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Nov 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2024

Major Issues Report

Form 8-K - Current report
Aug 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 18, 2024

Major Issues Report

Form 8-K - Current report
May 15, 2024

Major Issues Report

Form 8-K - Current report
May 15, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 02, 2024

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Mar 29, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Mar 18, 2024

Major Issues Report

Form 8-K - Current report